Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 6, 2006, Pages 1142-1147

  Severi, Gianluca ^a,b   Hayes, Vanessa M ^c   Neufing, Petra ^d,g   Padilla, Emma J D ^c   Tilley, Wayne D ^d,e   Eggleton, Sarah A ^c   Morris, Howard A ^e   English, Dallas R ^a,b   Southey, Melissa C ^b,f   Hopper, John L ^b   Sutherland, Robert L ^c   Boyle, Peter ^f   Giles, Graham G ^a,b  

^a CANCER EPIDEMIOLOGY CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e HANSON INSTITUTE   (Australia)

^f INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^g FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LINEAR REGRESSION ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROMOTER REGION; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PROSTATE CANCER; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; VARIATION (GENETICS);

EID: 33745712112     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0984     Document Type: Article

References (22)

1. Balk SP, Ko YJ, Bubley GJ. Biology of prostate-specific antigen. J Clin Oncol 2003;21:383-91.
2. Kim J, Coetzee GA. Prostate specific antigen gene regulation by androgen receptor. J Cell Biochem 2004;93:233-41.
3. Xue W, Irvine RA, Yu MC, Ross RK, Coetzee GA, Ingles SA. Susceptibility to prostate cancer: interaction between genotypes at the androgen receptor and prostate-specific antigen loci. Cancer Res 2000;60:839-41.
4. Xue WM, Coetzee GA, Ross RK, et al. Genetic determinants of serum prostate-specific antigen levels in healthy men from a multiethnic cohort. Cancer Epidemiol Biomarkers Prev 2001;10:575-9.
5. Medeiros R, Morais A, Vasconcelos A, et al. Linkage between polymorphisms in the prostate specific antigen ARE1 gene region, prostate cancer risk, and circulating tumor cells. Prostate 2002;53:88-94.
6. Gsur A, Preyer M, Haidinger G, et al. Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism, and prostate cancer risk. Carcinogenesis 2002;23:1647-51.
7. Chiang CH, Chen KK, Chang LS, Hong CJ. The impact of polymorphism on prostate specific antigen gene on the risk, tumor volume, and pathological stage of prostate cancer. J Urol 2004;171:1529-32.
8. Binnie MC, Alexander FE, Heald C, Habib FK. Polymorphic forms of prostate specific antigen and their interaction with androgen receptor trinucleotide repeats in prostate cancer. Prostate 2005;63:309-15.
9. Xu J, Meyers DA, Sterling DA, et al. Association studies of serum prostate-specific antigen levels and the genetic polymorphisms at the androgen receptor and prostate-specific antigen genes. Cancer Epidemiol Biomarkers Prev 2002;11:664-9.
10. Rao A, Chang BL, Hawkins G, et al. Analysis of G/A polymorphism in the androgen response element I of the PSA gene and its interactions with the androgen receptor polymorphisms. Urology 2003;61:864-9.
11. Wang LZ, Sato K, Tsuchiya N, et al. Polymorphisms in prostate-specific antigen (PSA) gene, risk of prostate cancer, and serum PSA levels in Japanese population. Cancer Lett 2003;202:53-9.
12. Salinas CA, Austin MA, Ostrander EO, Stanford JL. Polymorphisms in the androgen receptor and the prostate-specific antigen genes and prostate cancer risk. Prostate 2005;65:58-65.
13. Cramer SD, Chang BL, Rao A, et al. Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels. J Natl Cancer Inst 2003;95:1044-53.
14. Giles GG, Seven G, McCredie MR, et al. Smoking and prostate cancer: findings from an Australian case-control study. Ann Oncol 2001;12:761-5.
15. Severi G, Giles GG, Southey MC, et al. ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer. J Natl Cancer Inst 2003;95:818-24.
16. Giles GG, Severi G, Sinclair R, et al. Androgenetic alopecia and prostate cancer: findings from an Australian case-control study. Cancer Epidemiol Biomarkers Prev 2002;11:549-53.
17. AJCC. Prostate. American Joint Committee on Cancer: AJCC Cancer Staging Manual. New York: Springer; 2002. p. 309-16.
18. Hayes VM, Severi G, Padilla EJ, et al. Genetic variants in the vitamin D receptor gene and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2005;14:997-9.
19. Sham P. Statistics in human genetics. Applications of Statistics. London: Arnold; 1998.
20. Devlin B, Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 1995;29:311-22.
21. Breslow NE, Day NE. Statistical methods in cancer research. Volume. 1. The analysis of case-control studies. IARC Scientific Publications. Lyon: IARC; 1980.
22. Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model. Statistics for Biology and Health. New York: Springer-Verlag; 2000.